All blog posts
Showing 12 out of 77 results
18 March 2025
Navigating competition law and FDI regulation in the pharmaceuticals sector - 2025 Outlook
10 February 2025
Key Takeaways from the UPC Litigation Forum and Pharma & Biotech Patent Litigation Europe Summit 2025
30 January 2025
The UPC at 18 months
29 January 2025
Could we…and would we..? UK CoA confirms that it is bound by previous precedent on second medical use SPCs
29 January 2025
Transparency at the UPC – accessing information, pleadings and evidence
19 November 2024
Sustainability - trends and developments life sciences companies should be aware of
01 November 2024
EU Commission fines Teva €462.6 million for misuse of divisional patents and disparagement campaign
11 October 2024
The new UK Regulatory Innovation Office – a step in the right direction for UK life sciences
04 September 2024
CJEU finds EC's recent policy of referrals for deals below the merger thresholds illegal - more certainty for companies doing deals?
15 August 2024
H1 2024 – a steady start for biopharma M&A
07 August 2024
A new Labour Government – what might this mean for the UK life sciences industry?
01 August 2024
The EU AI Act Is In Force From Today (1 August 2024)
Showing 12 out of 77 results
View moreKey contacts
Laura Orlando
Italy Managing Partner, Joint Global Head of Intellectual Property, EMEA Co-Head of Life Sciences, Milan
